It was reported that transgenic introduction of human sclerostin could inhibit inflammatory cytokines and chemokines, while prevent AA and atherosclerosis progression in ApoE-/- mice with angiotensin II (AngII) infusion 12. This evidence concerns the gene SOST and atherosclerosis.